Cargando…
Toll-Like Receptor 3 and Suppressor of Cytokine Signaling Proteins Regulate CXCR4 and CXCR7 Expression in Bone Marrow-Derived Human Multipotent Stromal Cells
BACKGROUND: The use of bone marrow-derived human multipotent stromal cells (hMSC) in cell-based therapies has dramatically increased in recent years, as researchers have exploited the ability of these cells to migrate to sites of tissue injury, inflammation, and tumors. Our group established that hM...
Autores principales: | Tomchuck, Suzanne L., Henkle, Sarah L., Coffelt, Seth B., Betancourt, Aline M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382127/ https://www.ncbi.nlm.nih.gov/pubmed/22745793 http://dx.doi.org/10.1371/journal.pone.0039592 |
Ejemplares similares
-
A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
por: Waterman, Ruth S., et al.
Publicado: (2010) -
Stromal cell derived factor-1, CXCR4 and CXCR7 gene transcripts in pterygia
por: Bamdad, Shahram, et al.
Publicado: (2016) -
CXCR4 or CXCR7 antagonists treat endometriosis by reducing bone marrow cell trafficking
por: Pluchino, Nicola, et al.
Publicado: (2020) -
CXCR7 Controls Competition for Recruitment of β-Arrestin 2 in Cells Expressing Both CXCR4 and CXCR7
por: Coggins, Nathaniel L., et al.
Publicado: (2014) -
Stromal Derived Factor-1 (SDF-1) and Its Receptors CXCR4 and CXCR7 in Endometrial Cancer Patients
por: Walentowicz-Sadlecka, Malgorzata, et al.
Publicado: (2014)